RBC Europe’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,936
| Closed | -$401K | – | 969 |
|
|
2021
Q3 | $401K | Buy |
1,936
+325
| +20% | +$67.4K | 0.02% | 214 |
|
|
2021
Q2 | $342K | Hold |
1,611
| – | – | 0.02% | 240 |
|
|
2021
Q1 | $292K | Buy |
1,611
+1,440
| +842% | +$261K | 0.02% | 244 |
|
|
2020
Q4 | $19.1K | Sell |
171
-210
| -55% | -$23.4K | ﹤0.01% | 733 |
|
|
2020
Q3 | $41.3K | Buy |
381
+356
| +1,424% | +$38.6K | ﹤0.01% | 507 |
|
|
2020
Q2 | $2.08K | Sell |
25
-139
| -85% | -$11.6K | ﹤0.01% | 955 |
|
|
2020
Q1 | $2.23K | Hold |
164
| – | – | ﹤0.01% | 905 |
|
|
2019
Q4 | $653 | Hold |
164
| – | – | ﹤0.01% | 1004 |
|
|
2019
Q3 | $823 | Hold |
164
| – | – | ﹤0.01% | 996 |
|
|
2019
Q2 | $961 | Sell |
164
-1
| -0.6% | -$6 | ﹤0.01% | 1011 |
|
|
2019
Q1 | $1.82K | Hold |
165
| – | – | ﹤0.01% | 998 |
|
|
2018
Q4 | $6.06K | Buy |
165
+50
| +43% | +$1.84K | ﹤0.01% | 895 |
|
|
2018
Q3 | $4.32K | Hold |
115
| – | – | ﹤0.01% | 977 |
|
|
2018
Q2 | $3.08K | Hold |
115
| – | – | ﹤0.01% | 1025 |
|
|
2018
Q1 | $4.82K | Buy |
+115
| New | +$4.82K | ﹤0.01% | 950 |
|